Biota to ax a third of workers in R&D rejig; LabCentral launches in Kendall;

 @FierceBiotech: Analysis: 2012 life sciences VC fundraising and new bets shrivel. Article | Follow @FierceBiotech

 @RyanMFierce: Eli Lilly reports positive top-line results from 2 PhIIIs of GLP1 drug, but are they positive enough to rival others? Release | Follow @RyanMFierce

> Biota Pharmaceuticals plans to ax 30% of its workforce and relocate its headquarters to Atlanta as the company shifts its focus to clinical development. Item

> LabCentral has opened shop in Cambridge, Massachusetts' Kendall Square to incubate life sciences businesses. Report

> Eli Lilly ($LLY) reports positive top-line results of two Phase III trials for its drug dulaglutide to treat type 2 diabetes. Release

> AstraZeneca ($AZN) has inked a cancer biomarker discovery pact with Oxford Cancer Biomarkers to advance research of personalized oncology drugs. Report

> Based on the minutes of its meeting with the FDA, BioCryst Pharmaceuticals ($BCRX) has confirmed that the agency would accept an NDA for peramivir for acute uncomplicated influenza. Release

Pharma News

 @FiercePharma: Branded drug companies deny samples to would-be generics makers. How? REMS, partly. Article | Follow @FiercePharma

 @EricPFierce: Merck starts up $120 million China packaging plant but cuts manufacturing operations elsewhere. Story | Follow @EricPFierce

> Drugmakers 'illegally' withhold samples from would-be copycats. More

> J&J pharma growth drives big increase in Q1 sales, profits. Article

> AbbVie to hack hundreds of reps from cardiovascular sales ranks. Story

Medical Device News

 @FierceMedDev: At long last, Sony and Olympus launch medical device joint venture. News | Follow @FierceMedDev

 @MarkHFierce: The tech behind your old DVD player may have a second life as an HIV Dx tool. Story | Follow @MarkHFierce

 @DamianFierce: JNJ CFO says company still "going through the process" of deciding whether to sell/spin off diagnostics business. | Follow @DamianFierce

> Synthes buy props up weak device sales for J&J. Report

> Panasonic to sell stake in healthcare division. Item

> Is $13.6B too steep for Life Tech? More

> Supreme Court questions validity of Myriad's gene patents. Article

Pharma Manufacturing News

> U.S. contract manufacturers kick off expansions. Article

> Hospira again names an exec to get manufacturing in order. News

> Bristol-Myers Squibb marries early-stage processes to biologics manufacturing. Article

Biotech Research News

 @EmilyMFierce: Is the World's Top Neuroscience Group Quashing Dissent on the U.S. BRAIN Initiative? More | Follow @EmilyMFierce

> Scientists develop technique to rebuild brain cells destroyed by MS, cerebral palsy. Report

> Mersana's cancer drug technology cures tumors in mice at low doses. Story

> New rat model could help scientists better understand, treat Alzheimer's. Article

> Role of brain enzyme linked to neurodegeneration in mice. Item

And Finally… Sanofi ($SNY) CEO Chris Viehbacher was criticized for his comments about steering his company away from risky Alzheimer's R&D. Article

Suggested Articles

Journey Colab launches with $3 million from Apollo Projects to develop a pipeline of psychedelic compounds through a new development model.

Forma's lead asset, an IDH1 inhibitor, cleared cancer in one-third of patients with relapsed or refractory acute myeloid leukemia.

A type of white blood cell known as a granulocyte secretes growth factors that help axons of the central nervous system regenerate, researchers found.